Introduction to Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic, progressive, systemic autoimmune disease characterized primarily by persistent inflammation of the synovial joints. Unlike osteoarthritis, which develops due to mechanical wear and tear of cartilage over time, rheumatoid arthritis occurs because the body's immune system mistakenly attacks its own tissues, especially the synovial membrane that lines joints. This abnormal immune response initiates a cascade of inflammatory events that gradually destroy cartilage, erode bone, deform joints, and eventually involve multiple organs throughout the body.
Rheumatoid arthritis affects approximately 0.5–1% of the global population and occurs more commonly in women than men, with a female-to-male ratio of nearly 3:1. The disease can occur at any age but most commonly begins between the ages of 30 and 60 years. Although the exact cause remains incompletely understood, genetic susceptibility combined with environmental triggers plays a central role in disease development.
The hallmark feature of rheumatoid arthritis is that it is not merely a disease of the joints. It is a systemic inflammatory disorder capable of affecting the cardiovascular system, lungs, kidneys, eyes, nervous system, skin, and blood vessels. For this reason, rheumatoid arthritis is increasingly considered a whole-body disease rather than simply a musculoskeletal condition.
The Autoimmune Nature of Rheumatoid Arthritis
The fundamental abnormality in rheumatoid arthritis lies within the immune system. Under normal circumstances, immune cells protect the body against bacteria, viruses, fungi, and malignant cells while maintaining tolerance toward the body's own tissues. In rheumatoid arthritis, this self-tolerance is lost.
The immune system begins to identify proteins within the synovial tissues as foreign antigens and launches an attack against them. This process involves both innate and adaptive immune responses. T lymphocytes, B lymphocytes, macrophages, dendritic cells, neutrophils, and plasma cells infiltrate the synovial membrane and release numerous inflammatory mediators that perpetuate tissue damage.
Activated CD4+ helper T cells play a pivotal role by producing cytokines that stimulate macrophages and B cells. B lymphocytes contribute by producing autoantibodies, particularly rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP). These autoantibodies form immune complexes that deposit within synovial tissues and amplify inflammation.
Instead of resolving after eliminating an infection, the inflammatory response in rheumatoid arthritis becomes self-sustaining. The immune system essentially remains switched on continuously, causing ongoing tissue destruction over months and years.
Genetic Predisposition and Susceptibility
Genetic factors contribute significantly to the development of rheumatoid arthritis. The strongest association exists with genes located within the human leukocyte antigen (HLA) region, particularly HLA-DR4 and HLA-DR1 alleles.
These genes encode proteins responsible for presenting antigens to T lymphocytes. Certain HLA variants appear to present self-antigens in a manner that promotes autoimmunity. Individuals carrying these alleles have a substantially increased risk of developing rheumatoid arthritis, especially severe and erosive disease.
However, genetics alone cannot explain the disease because many individuals with these genes never develop rheumatoid arthritis. This observation highlights the importance of environmental factors acting on genetically susceptible individuals.
Additional genes involved in immune regulation, cytokine signaling, and lymphocyte activation have also been implicated, including PTPN22, STAT4, CTLA4, and TNFAIP3. These genetic abnormalities influence immune tolerance and inflammatory pathways, making autoimmunity more likely.
Environmental Triggers That Initiate Disease
Environmental factors often act as triggers that initiate rheumatoid arthritis in genetically predisposed individuals. Among these triggers, cigarette smoking is considered one of the strongest and most extensively studied risk factors.
Smoking promotes inflammation within the lungs and induces a process known as citrullination, in which proteins undergo post-translational modification and become antigenic. The immune system may recognize these altered proteins as foreign, resulting in anti-CCP antibody formation years before clinical symptoms appear.
Several infectious agents have also been proposed as triggers. Organisms such as Epstein-Barr virus, Proteus species, and Porphyromonas gingivalis have attracted attention because they may induce molecular mimicry, whereby microbial antigens resemble self-antigens and provoke autoimmune responses.
Hormonal influences are suggested by the predominance of rheumatoid arthritis in women. Estrogen and progesterone may modulate immune activity and contribute to disease susceptibility. Pregnancy often alters disease activity, further supporting the role of hormonal regulation.
Other potential risk factors include obesity, air pollution, occupational silica exposure, periodontal disease, dietary factors, and chronic psychological stress.
The Role of Citrullination in Autoimmunity
One of the most important discoveries in rheumatoid arthritis research is the role of citrullination in disease initiation.
Citrullination is a normal biochemical process in which the amino acid arginine is converted into citrulline by enzymes called peptidylarginine deiminases (PAD enzymes). Under inflammatory conditions, excessive citrullination occurs, generating altered proteins that may no longer be recognized as self by the immune system.
The body subsequently produces anti-citrullinated protein antibodies, commonly referred to as anti-CCP antibodies. These antibodies can be detected years before symptoms begin and are highly specific for rheumatoid arthritis.
Once formed, anti-CCP antibodies bind to citrullinated proteins within joints and create immune complexes. These complexes activate complement pathways and attract inflammatory cells into the synovium, intensifying tissue injury.
Patients with anti-CCP positivity often experience more aggressive disease, faster joint destruction, and a greater likelihood of extra-articular complications.
Synovial Inflammation: The First Step in Joint Destruction
The earliest pathological event within affected joints is inflammation of the synovial membrane, a condition known as synovitis.
The synovium normally consists of a thin membrane responsible for producing synovial fluid that lubricates joints and nourishes cartilage. In rheumatoid arthritis, inflammatory cells infiltrate this delicate tissue and transform it into a thick, highly vascular, aggressive inflammatory mass.
The synovial membrane becomes swollen due to edema and cellular proliferation. Blood vessels multiply rapidly in response to inflammatory mediators, increasing blood flow to affected joints and producing warmth and redness.
Patients begin experiencing pain, swelling, tenderness, and prolonged morning stiffness, often lasting longer than one hour. The stiffness improves with movement because activity disperses inflammatory mediators accumulated during periods of rest.
Symmetrical involvement of small joints of the hands and feet is characteristic of rheumatoid arthritis. The metacarpophalangeal joints, proximal interphalangeal joints, wrists, and metatarsophalangeal joints are frequently affected early in the disease process.
Cytokine Storm Within the Rheumatoid Joint
The inflamed rheumatoid joint contains extraordinarily high concentrations of inflammatory cytokines that perpetuate disease activity.
Tumor necrosis factor-alpha (TNF-α) is among the most important cytokines involved in rheumatoid arthritis. It stimulates leukocyte recruitment, promotes angiogenesis, activates osteoclasts, and induces the production of additional cytokines.
Interleukin-1 contributes to cartilage degradation and bone resorption while enhancing inflammatory cell activity.
Interleukin-6 plays a major role in systemic manifestations including anemia, fatigue, fever, and increased hepatic production of acute-phase reactants such as C-reactive protein.
Interleukin-17 produced by Th17 lymphocytes recruits neutrophils and amplifies local tissue destruction.
Granulocyte-macrophage colony-stimulating factor further activates macrophages and perpetuates inflammation.
The interaction of these cytokines creates a self-amplifying inflammatory cycle that persists even in the absence of an external trigger.
Formation of Pannus and Aggressive Synovial Tissue
One of the defining pathological features of rheumatoid arthritis is the development of pannus.
Pannus is an abnormal layer of proliferating inflammatory tissue that forms over articular cartilage and invades adjacent structures. It contains fibroblasts, macrophages, lymphocytes, plasma cells, and newly formed blood vessels.
Rather than functioning as a protective tissue, pannus behaves similarly to an invasive tumor. It aggressively grows across cartilage surfaces and releases enzymes capable of digesting extracellular matrix components.
Matrix metalloproteinases secreted by synovial fibroblasts degrade collagen and proteoglycans that form the structural framework of cartilage. Chondrocytes become damaged and eventually die, impairing the ability of cartilage to repair itself.
As the pannus enlarges, it progressively erodes cartilage, invades subchondral bone, and destroys supporting ligaments and tendons.
This destructive process is largely irreversible and represents the major cause of permanent disability in rheumatoid arthritis.
Cartilage Destruction and Loss of Joint Function
Articular cartilage is a specialized connective tissue that provides a smooth, low-friction surface for movement and distributes mechanical loads across joints.
Inflammatory cytokines and proteolytic enzymes gradually degrade cartilage matrix components, including type II collagen and aggrecan. Since cartilage lacks blood vessels and possesses limited regenerative capacity, even minor damage accumulates over time.
As cartilage thins, opposing bone surfaces begin to rub directly against one another during movement. Friction increases dramatically, causing pain, crepitus, stiffness, and reduced mobility.
Patients frequently notice difficulty performing fine motor activities such as buttoning clothes, opening jars, writing, or turning keys. Grip strength declines progressively as hand joints become increasingly damaged.
Loss of cartilage also contributes to joint instability because the normal congruency between articulating surfaces is lost. This instability accelerates further structural damage and deformity.
Bone Erosion and Osteoclast Activation
Bone destruction in rheumatoid arthritis occurs primarily through activation of osteoclasts, the specialized cells responsible for bone resorption.
Inflammatory cytokines stimulate expression of receptor activator of nuclear factor kappa-B ligand (RANKL), a molecule essential for osteoclast differentiation and activation.
Activated osteoclasts accumulate along the margins of joints and begin resorbing cortical and trabecular bone. Small erosions become visible on imaging studies and gradually enlarge over time.
Unlike osteoporosis, which causes generalized reduction in bone density, rheumatoid arthritis produces localized erosions concentrated near inflamed joints.
Bone erosion is considered a marker of aggressive disease and correlates strongly with long-term disability and functional impairment.
Early initiation of disease-modifying antirheumatic therapy is therefore essential to prevent irreversible structural damage and preserve joint function.
Tendon Damage and Ligament Destruction
Rheumatoid arthritis does not limit its destructive effects to cartilage and bone alone. The inflammatory process extends into tendons, tendon sheaths, ligaments, and surrounding soft tissues, leading to profound instability of affected joints.
Tendons are responsible for transmitting the force generated by muscles to bones, allowing movement to occur. In rheumatoid arthritis, inflammation of tendon sheaths, known as tenosynovitis, develops as inflammatory cells infiltrate these structures. Swollen tendon sheaths become painful and movement becomes difficult.
The flexor tendons of the fingers and the extensor tendons of the wrists are particularly vulnerable. Chronic inflammation weakens tendon fibers and reduces their elasticity and strength. Over time, tendons may fray and eventually rupture completely.
A ruptured extensor tendon in the hand may cause a finger to suddenly lose the ability to straighten, while rupture of flexor tendons impairs gripping and fine motor activities. Tendon rupture is often a late manifestation of poorly controlled disease and can significantly impair hand function.
Ligaments are similarly affected. Persistent inflammation causes stretching and weakening of ligamentous support structures, resulting in joint laxity and instability. When ligaments can no longer maintain proper alignment of bones, deformities gradually develop.
Development of Characteristic Hand Deformities
The hands are among the most commonly affected sites in rheumatoid arthritis and often exhibit characteristic deformities that are highly suggestive of the diagnosis.
One of the earliest abnormalities is ulnar deviation of the fingers at the metacarpophalangeal joints. As ligaments weaken and joint destruction progresses, the fingers drift toward the ulnar side of the hand, creating the classic appearance of rheumatoid hands.
Swan-neck deformity develops when there is hyperextension of the proximal interphalangeal joint combined with flexion of the distal interphalangeal joint. This deformity interferes with grasping and fine manipulation of objects.
Boutonniere deformity is another common abnormality characterized by flexion of the proximal interphalangeal joint and hyperextension of the distal interphalangeal joint. It occurs due to disruption of the extensor tendon mechanism.
Z-thumb deformity involves hyperextension of the interphalangeal joint and flexion of the metacarpophalangeal joint of the thumb, significantly impairing pinch function.
As these deformities become established, they often become irreversible even if inflammation is later controlled.
Damage to the Wrist and Loss of Hand Function
The wrist is frequently involved early in rheumatoid arthritis and often sustains severe damage because of its complex anatomy and numerous articulations.
Synovial inflammation causes swelling and tenderness around the wrist joint. Patients may initially complain of difficulty opening doors, lifting objects, or supporting body weight with their hands.
Progressive cartilage destruction and bone erosion eventually result in collapse of the carpal bones and instability of the wrist joint. Range of motion becomes increasingly restricted, and activities requiring flexion, extension, or rotation become difficult.
Median nerve compression within the carpal tunnel may occur secondary to synovial swelling, resulting in numbness, tingling, and weakness of the thumb, index finger, middle finger, and radial half of the ring finger.
Carpal tunnel syndrome is therefore considerably more common among patients with rheumatoid arthritis than in the general population.
Advanced wrist destruction may eventually require surgical stabilization or joint replacement procedures.
Involvement of the Feet and Ankle Joints
Foot involvement is extremely common in rheumatoid arthritis and may occur early in the disease course, sometimes even before hand symptoms become prominent.
The metatarsophalangeal joints are particularly susceptible to inflammation. Patients often experience pain while walking, standing for prolonged periods, or wearing tight footwear.
As inflammation persists, destruction of supporting ligaments causes subluxation and displacement of the metatarsal heads. This results in abnormal pressure distribution across the foot and the development of painful calluses.
Hallux valgus, commonly known as bunion formation, frequently occurs due to deformity of the first metatarsophalangeal joint.
Hammer toes and claw toes may develop because of tendon imbalance and joint instability. These deformities interfere with walking and can make footwear selection difficult.
Ankle involvement causes pain, swelling, and instability that further impair mobility and increase the risk of falls.
Severe foot deformities are a major contributor to disability and loss of independence in patients with long-standing rheumatoid arthritis.
Cervical Spine Involvement and Neurological Risk
Unlike osteoarthritis, rheumatoid arthritis can affect the cervical spine, particularly the atlantoaxial joint located between the first and second cervical vertebrae.
Inflammation weakens the ligaments stabilizing this region and may result in atlantoaxial subluxation. Because the spinal cord passes directly through this area, instability can become potentially life-threatening.
Patients may experience neck pain, occipital headaches, stiffness, or sensations of clicking during neck movement. In severe cases, compression of the spinal cord may occur.
Neurological symptoms can include weakness, numbness, gait disturbance, impaired coordination, hyperreflexia, and bladder dysfunction.
Untreated cervical instability carries the risk of sudden spinal cord injury and respiratory compromise. Consequently, evaluation of cervical spine involvement is important before surgical procedures requiring endotracheal intubation.
Modern treatment strategies have significantly reduced the incidence of severe cervical complications, but they remain an important consideration in patients with long-standing disease.
Why Rheumatoid Arthritis Causes Morning Stiffness
Morning stiffness lasting more than one hour is one of the classic clinical features of rheumatoid arthritis and provides valuable diagnostic information.
During periods of inactivity, inflammatory mediators accumulate within affected joints. Synovial fluid becomes enriched with cytokines, immune complexes, and inflammatory cells.
When patients awaken after several hours of immobility, these inflammatory substances create resistance to movement and contribute to stiffness and discomfort.
As joints begin moving, synovial fluid circulation improves and inflammatory mediators become dispersed. This gradually reduces stiffness and improves mobility.
The duration of morning stiffness often correlates with disease activity. Active disease may produce stiffness lasting several hours, whereas effective treatment can reduce this duration substantially.
This characteristic distinguishes inflammatory arthritis from degenerative conditions such as osteoarthritis, where stiffness is usually brief and lasts less than thirty minutes.
Systemic Inflammation: Why Rheumatoid Arthritis Becomes a Whole-Body Disease
Rheumatoid arthritis is fundamentally a systemic inflammatory disorder rather than an isolated joint disease.
Inflammatory cytokines produced within joints enter the bloodstream and circulate throughout the body, affecting distant organs and tissues. Persistent systemic inflammation places considerable metabolic stress on multiple organ systems.
Patients often experience generalized fatigue, malaise, weight loss, loss of appetite, low-grade fever, and reduced exercise tolerance even before significant joint damage occurs.
The liver responds to inflammatory signals by producing acute-phase proteins such as C-reactive protein and fibrinogen. The bone marrow alters blood cell production, contributing to anemia and thrombocytosis.
Muscle tissue undergoes catabolism under the influence of inflammatory cytokines, leading to weakness and loss of muscle mass.
This widespread inflammatory response explains why rheumatoid arthritis is associated with increased cardiovascular morbidity and reduced life expectancy if inadequately treated.
Rheumatoid Arthritis and Chronic Fatigue
Fatigue is among the most disabling symptoms experienced by patients with rheumatoid arthritis and often exceeds joint pain in terms of impact on quality of life.
Several mechanisms contribute to this profound fatigue. Chronic inflammation increases metabolic demands and disrupts normal energy regulation pathways.
Inflammatory cytokines such as TNF-alpha and interleukin-6 directly affect the central nervous system and alter neurotransmitter function, producing sensations of exhaustion and reduced motivation.
Pain interferes with sleep quality, while depression and anxiety may further exacerbate fatigue.
Anemia of chronic disease reduces oxygen delivery to tissues and contributes additional symptoms of weakness and reduced stamina.
Unlike ordinary tiredness that improves with rest, rheumatoid fatigue may persist despite adequate sleep and can significantly impair occupational and social functioning.
Rheumatoid Nodules: The Skin Manifestation of Severe Disease
Rheumatoid nodules are among the most characteristic extra-articular manifestations of rheumatoid arthritis.
These firm, non-tender subcutaneous nodules typically develop over pressure points such as the elbows, fingers, Achilles tendons, and forearms.
Histologically, they consist of a central area of fibrinoid necrosis surrounded by inflammatory cells and fibrous tissue.
Rheumatoid nodules occur more frequently in patients with positive rheumatoid factor and severe disease activity. Their presence often indicates more aggressive systemic inflammation.
Although usually painless, nodules may become ulcerated, infected, or interfere with movement if located near joints or tendons.
In rare cases, similar nodules can develop internally within the lungs, heart, or other organs, reflecting the systemic nature of the disease.
Anemia of Chronic Disease in Rheumatoid Arthritis
Anemia is one of the most common hematological abnormalities in rheumatoid arthritis and contributes significantly to fatigue and reduced exercise tolerance.
Inflammation stimulates production of hepcidin, a liver-derived hormone that reduces intestinal iron absorption and traps iron within macrophages.
As a result, iron becomes unavailable for red blood cell production despite adequate total body iron stores.
Inflammatory cytokines also suppress erythropoietin production and impair bone marrow responsiveness to erythropoietin stimulation.
The resulting anemia is typically normocytic and normochromic, although iron deficiency may coexist in some patients.
Correction of anemia often requires effective control of underlying inflammation rather than simple iron supplementation alone.
How Rheumatoid Arthritis Damages the Cardiovascular System
Cardiovascular disease is one of the leading causes of death among patients with rheumatoid arthritis. Chronic systemic inflammation accelerates the development of atherosclerosis and places continuous stress on the heart and blood vessels.
Inflammatory cytokines damage the endothelial lining of arteries, impairing their normal protective functions. The injured endothelium becomes more permeable to lipids and inflammatory cells, promoting the formation of atherosclerotic plaques.
As plaque formation progresses, coronary arteries gradually narrow, reducing blood supply to the heart muscle. Consequently, patients with rheumatoid arthritis have a significantly increased risk of myocardial infarction, angina, and sudden cardiac death compared with the general population.
The risk of cardiovascular disease in rheumatoid arthritis has been compared to that seen in diabetes mellitus because of the persistent inflammatory burden.
Inflammation also promotes thrombosis by increasing fibrinogen levels and platelet activation, making blood more likely to clot. This contributes further to the risk of stroke and other vascular complications.
Importantly, cardiovascular disease may develop silently in rheumatoid arthritis patients, making regular assessment of cardiovascular risk factors an essential component of long-term management.
Pericarditis: Inflammation Around the Heart
One of the direct cardiac manifestations of rheumatoid arthritis is pericarditis, which refers to inflammation of the pericardium surrounding the heart.
The inflamed pericardial membranes become thickened and may produce excess fluid, leading to pericardial effusion.
Small effusions may remain asymptomatic and are discovered incidentally during imaging studies. Larger effusions, however, can cause chest pain, shortness of breath, and palpitations.
The chest pain associated with pericarditis often worsens when lying flat and improves when sitting forward.
In severe cases, fluid accumulation may compress the heart and impair its ability to pump blood effectively, a condition known as cardiac tamponade.
Fortunately, severe pericardial complications are uncommon in the modern era because effective immunosuppressive therapies control systemic inflammation more successfully than older treatment strategies.
Myocarditis and Damage to the Heart Muscle
Inflammation in rheumatoid arthritis can occasionally extend directly into the myocardium, the muscular layer of the heart.
Myocarditis may interfere with the heart's electrical conduction system and reduce myocardial contractility.
Patients can present with fatigue, shortness of breath, chest discomfort, palpitations, or exercise intolerance.
Persistent inflammation may eventually contribute to dilated cardiomyopathy and chronic heart failure.
Fibrosis within the conduction system can also lead to arrhythmias and conduction abnormalities.
Although clinically significant myocarditis is relatively uncommon, subclinical myocardial involvement may be more frequent than previously recognized and contributes to the increased cardiovascular mortality observed in rheumatoid arthritis patients.
Rheumatoid Arthritis and Blood Vessel Inflammation
Rheumatoid vasculitis represents one of the most serious extra-articular manifestations of severe rheumatoid arthritis.
In this condition, inflammatory cells attack the walls of small and medium-sized blood vessels throughout the body.
The resulting vascular inflammation narrows the vessel lumen and reduces blood flow to tissues supplied by affected arteries.
Cutaneous manifestations may include skin ulcers, purpura, nail fold infarcts, and areas of tissue necrosis.
If nerves are involved, patients may develop peripheral neuropathy characterized by numbness, weakness, burning pain, or loss of sensation.
In severe cases, vasculitis may affect internal organs such as the intestines, kidneys, or heart, resulting in life-threatening complications.
Rheumatoid vasculitis is most commonly associated with long-standing disease, high rheumatoid factor titers, and poorly controlled inflammation.
Pulmonary Involvement in Rheumatoid Arthritis
The lungs are among the most frequently affected extra-articular organs in rheumatoid arthritis.
Pulmonary complications contribute substantially to morbidity and mortality and may occasionally appear before joint symptoms become obvious.
Inflammation may affect the pleura, lung interstitium, airways, and pulmonary vasculature.
Patients commonly develop chronic cough, progressive shortness of breath, chest discomfort, or reduced exercise tolerance.
Because pulmonary manifestations can mimic infection or other respiratory diseases, diagnosis often requires imaging studies and pulmonary function testing.
Recognition of lung involvement is important because some pulmonary complications progress silently before symptoms become apparent.
Interstitial Lung Disease and Progressive Fibrosis
Interstitial lung disease is one of the most serious pulmonary complications associated with rheumatoid arthritis.
Chronic inflammation damages the delicate alveolar walls and surrounding interstitial tissues, resulting in fibrosis and scarring.
As scar tissue accumulates, lung compliance decreases and breathing becomes increasingly difficult.
Patients often notice gradual onset of exertional dyspnea and a persistent dry cough.
Physical examination may reveal fine inspiratory crackles that resemble the sound of separating Velcro strips.
High-resolution computed tomography frequently demonstrates reticular opacities, honeycombing, and areas of fibrosis.
Advanced pulmonary fibrosis severely impairs oxygen exchange and may ultimately lead to respiratory failure.
Smoking and anti-CCP positivity appear to increase the risk of developing rheumatoid-associated interstitial lung disease.
Pleuritis and Pleural Effusion
Inflammation of the pleural membranes surrounding the lungs is another recognized manifestation of rheumatoid arthritis.
Pleuritis causes sharp chest pain that worsens with deep inspiration, coughing, or sneezing.
Inflammatory fluid may accumulate between the pleural layers, producing pleural effusion.
Small effusions may produce no symptoms, whereas larger collections can cause significant breathlessness.
Pleural fluid associated with rheumatoid arthritis often demonstrates low glucose concentrations and elevated inflammatory markers.
Repeated episodes of pleural inflammation may eventually lead to pleural thickening and restriction of lung expansion.
Rheumatoid Nodules Within the Lungs
Just as rheumatoid nodules can occur beneath the skin, similar lesions may develop within lung tissue.
Pulmonary rheumatoid nodules are usually asymptomatic and are often discovered incidentally during chest imaging.
These nodules may be solitary or multiple and vary considerably in size.
Occasionally they may cavitate, rupture, or become infected, resulting in cough, hemoptysis, or pneumothorax.
Because pulmonary nodules can resemble malignancy or tuberculosis on imaging studies, additional evaluation is often necessary to establish the diagnosis.
Airway Disease in Rheumatoid Arthritis
Inflammation may involve both large and small airways in rheumatoid arthritis.
Bronchiolitis develops when inflammation affects the small bronchioles, leading to airflow obstruction and progressive respiratory symptoms.
Patients may experience wheezing, cough, and exertional breathlessness.
Bronchiectasis can also occur due to chronic airway inflammation and recurrent infections.
In bronchiectasis, permanent dilation of bronchi impairs mucus clearance and predisposes patients to repeated bacterial infections.
This combination of chronic inflammation and recurrent infection can contribute significantly to declining pulmonary function over time.
Ocular Complications of Rheumatoid Arthritis
The eyes are another common target of systemic inflammation in rheumatoid arthritis.
Dry eye syndrome, also known as keratoconjunctivitis sicca, occurs when inflammation damages the lacrimal glands and reduces tear production.
Patients frequently complain of burning, grittiness, redness, irritation, and sensitivity to light.
Untreated dry eyes increase the risk of corneal ulceration and visual impairment.
Inflammation may also involve deeper ocular structures, producing episcleritis, scleritis, and uveitis.
Among these conditions, scleritis is particularly serious because it may threaten vision if left untreated.
Severe ocular pain, redness, and photophobia require urgent ophthalmological evaluation.
Secondary Sjögren Syndrome in Rheumatoid Arthritis
Many patients with rheumatoid arthritis develop secondary Sjögren syndrome, another autoimmune disorder characterized by destruction of exocrine glands.
The salivary and lacrimal glands are most commonly affected.
Reduced saliva production causes persistent dry mouth, difficulty swallowing dry foods, altered taste sensation, and increased dental caries.
Reduced tear production leads to chronic eye discomfort and irritation.
Patients may also experience dryness of the nasal passages, throat, and skin.
The coexistence of Sjögren syndrome further illustrates the widespread immune dysregulation underlying rheumatoid arthritis.
Neurological Complications of Rheumatoid Arthritis
Neurological involvement in rheumatoid arthritis may occur through several mechanisms including vasculitis, nerve compression, cervical spine instability, and chronic inflammation.
Peripheral neuropathy is among the most common manifestations and presents with numbness, tingling, burning sensations, or weakness in the limbs.
Entrapment neuropathies such as carpal tunnel syndrome occur because swollen synovial tissues compress adjacent nerves.
Mononeuritis multiplex may develop when vasculitis compromises blood supply to peripheral nerves.
Cervical spinal cord compression resulting from atlantoaxial instability represents one of the most serious neurological complications and may cause weakness, gait abnormalities, or paralysis if not recognized promptly.
The nervous system involvement associated with rheumatoid arthritis further emphasizes that the disease extends far beyond the joints themselves.
